NET PROFIT (x1000 EUR)
EMPLOYEES
Sixera Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
2
|
1
|
2 |
Earnings before taxes |
-644
|
-831
|
-1,015 |
EBITDA |
-644
|
-830
|
-1,013 |
Total assets |
645
|
667
|
1,683 |
Current assets |
600
|
623
|
1,634 |
Current liabilities |
178
|
189
|
257 |
Equity capital |
422
|
434
|
1,377 |
- share capital |
9
|
8
|
9 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
65.4%
|
65.1%
|
81.8% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-99.5%
|
-124.4%
|
-60.2% |
Current ratio |
337.1%
|
329.6%
|
635.8% |
Return on equity (ROE) |
-152.6%
|
-191.5%
|
-73.7% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.